Achalasia: Incidence, prevalence and survival. A population-based study

Neurogastroenterology and Motility

Volumn 22, Issue 9, 2010, Pages

  Sadowski, D C ^a   Ackah, F ^b   Jiang, B ^c   Svenson, L W ^a,d  

^a UNIVERSITY OF ALBERTA   (Canada)

^b ALBERTA ENVIRONMENT AND PARKS   (Canada)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

achalasia; epidemiology

Indexed keywords

ADULT; AGED; ARTICLE; BALLOON DILATATION; CANADA; CHILD; CONTROLLED STUDY; DATA BASE; ENDOSCOPIC SURGERY; ESOPHAGUS ACHALASIA; ESOPHAGUS MYOTOMY; FEMALE; HEALTH INSURANCE; HOSPITAL BILLING; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PATIENT INFORMATION; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALBERTA; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; ESOPHAGEAL ACHALASIA; FEMALE; HUMANS; INCIDENCE; INTERNATIONAL CLASSIFICATION OF DISEASES; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PREVALENCE; SURVIVAL RATE;

EID: 77955462099     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2010.01511.x     Document Type: Article

References (27)

1. Park W, Vaezi MF. Etiology and pathogenesis of achalasia: the current understanding. Am J Gastroenterol 2005 100 : 1404 1414.
2. Kraichely RE, Farrugia G, Pittock SJ et al. Neural autoantibody profile of primary achalasia. Dig Dis Sci 2010 55 : 307 311.
3. Paladini F, Cocco E, Cascino I et al. Age-dependent association of idiopathic achalasia with vasoactive intestinal peptide receptor 1 gene. Neurogastroenterol Motil 2009 21 : 597 602.
4. Facco M, Brun P, Baesso I et al. T cells in the myenteric plexus of achalasia patients show a skewed TCR repertoire and react to HSV-1 antigens. Am J Gastroenterol 2008 103 : 1598 1609.
5. Robertson CS, Martin BA, Altinson M. Varicella-zooster virus DNA in the oesophageal myenteric plexus in achalasia. Gut 1993 34 : 299 302.
6. Mayberrry JF, Atkinson M. Variations in the prevalence of achalasia in Great Britain and Ireland: an epidemiological study based on hospital admissions. Q J Med 1987 62 : 67 74.
7. Mayberry JF, Atkinson M. Studies of the incidence and prevalence of achalasia in the Nottingham area. Q J Med 1985 56 : 451 456.
8. Mayberry JF, Rhodes J. Achalasia in the city of Cardiff from 1926 to 1977. Digestion 1980 20 : 248 252.
9. Birgisson S, Richter JE. Achalasia in Iceland, 1952-2002: an epidemiological study. Dig Dis Sci 2007 52 : 1855 1860.
10. Ho KY, Tay H-H, Kang JY. A prospective study of the clinical features, manometric findings, incidence and prevalence of achalasia in Singapore. J Gastroenterol Hepatol 1999 14 : 791 795.
11. Howard PJ, Maher L, Pryde A et al. A five year prospective study of the incidence, clinical features, and diagnoses of achalasia in Edinburgh. Gut 1992 33 : 1011 1015.
12. Mayberry JF, Atkinson M. Incidence of achalasia in New Zealand, 1980-84: an epidemiological study based on hospital discharges. J Gastroenterol Hepatol 1988 3 : 247 252.
13. Ruiz-de-Leon A, Mendoza J, Sevilla-Mantilla C et al. Myenteric antiplexus antibodies and class II HLA in achalasia. Dig Dis Sci 2002 47 : 15 9.
14. Farrukh A, DeCaestecker J, Mayberry JF. An epidemiological study of achalasia among the south Asian population of Leicester, 1986-2005. Dysphagia 2008 23 : 161 164.
15. Sonnenberg A. Hospitalization for achalasia in the United States 1997-2006. Dig Dis Sci 2009 54 : 1680 1685.
16. Eckardt VF, Hoischen T, Bernhard G. Life expectancy, complications, and causes of death in patients with achalasia: results of a 33-year follow-up investigation. Eur J Gastroenterol Hepatol 2008 20 : 956 960.
17. Rantanen TK, Sihvo EI, Räsänen JV, Salo JA. Gastroesophageal reflux disease as a cause of death is increasing: analysis of fatal cases after medical and surgical treatment. Am J Gastroenterol 2007 102 : 246 253.
18. Johnson JA, Balko SU, Hugel G, Low C, Svenson LW. Increasing incidence and prevalence with limited survival gains among rural Albertans with diabetes: a retrospective cohort study, 1995-2006. Diabet Med 2009 26 : 989 995.
19. Pasricha PJ, Rai R, Ravich WJ et al. Botulinum toxin for achalasia: long-term outcome and predictors of response. Gastroenterology 1996 110 : 1410 1415.
20. Annese V, Bassotti G, Coccia G et al. A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group. Gut 2000 46 : 597 600.
21. Wang L, Li YM, Li L. Meta-analysis of randomized and controlled treatment trials for achalasia. Dig Dis Sci 2009 54 : 2303 2311.
22. Studney DR, Hakstian AR. A comparison of medical record with billing diagnostic information associated with ambulatory medical care. Am J Public Health 1981 71 : 145 149.
23. Warren S, Warren KG. Prevalence, incidence and characteristics of multiple sclerosis in Westlock County, Alberta, Canada. Neurology 1993 43 : 1760 1763.
24. Patten SB, Svenson LW, White CM et al. Affective disorders in motor neuron disease: a population-based study. Neuroepidemiology 2007 28 : 1 7.
25. Hauck LJ, White C, Feasby TE et al. Incidence of Guillain-Barré syndrome in Alberta, Canada: an administrative data study. J Neurol Neurosurg Psychiatry 2008 79 : 318 320.
26. Gao S, Manns BJ, Culleton BF et al. Prevalence of chronic kidney disease and survival among aboriginal people. J Am Soc Nephrol 2007 18 : 2953 2959.
27. Hux JE, Ivis F, Flintoft V et al. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 2002 25 : 512 516.